Medexus Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Medexus Pharmaceuticals has a total shareholder equity of $32.7M and total debt of $42.5M, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are $145.4M and $112.6M respectively. Medexus Pharmaceuticals's EBIT is $12.8M making its interest coverage ratio 1.4. It has cash and short-term investments of $7.0M.
Key information
129.8%
Debt to equity ratio
US$42.50m
Debt
| Interest coverage ratio | 1.4x |
| Cash | US$6.97m |
| Equity | US$32.74m |
| Total liabilities | US$112.63m |
| Total assets | US$145.37m |
Recent financial health updates
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Nov 05
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Recent updates
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Nov 05There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings
Aug 19Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 10Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth
Jul 31The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet
Jun 15Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive
Mar 03Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story
Jan 06Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors
Oct 11Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Financial Position Analysis
Short Term Liabilities: MDP's short term assets ($64.2M) exceed its short term liabilities ($63.4M).
Long Term Liabilities: MDP's short term assets ($64.2M) exceed its long term liabilities ($49.2M).
Debt to Equity History and Analysis
Debt Level: MDP's net debt to equity ratio (108.5%) is considered high.
Reducing Debt: MDP's debt to equity ratio has increased from 70.4% to 129.8% over the past 5 years.
Debt Coverage: MDP's debt is well covered by operating cash flow (52.2%).
Interest Coverage: MDP's interest payments on its debt are not well covered by EBIT (1.4x coverage).